Live feed17:01:57·1426dSECFilingvia QuantisnowSilverback Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Costs Associated with Exit or Disposal Activities, Leadership Update, Other Events, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.SBTX· Silverback Therapeutics Inc.Consumer DiscretionaryOriginal source
